Several epidemiological studies and clinical investigations have demonstrated an inverse correlation between adiponectin levels and the risk of developing breast cancer, as well as an association between lower adiponectin levels and more advanced stages of malignancy [35]. This evidence concerns the gene ADIPOQ and breast carcinoma.